Do ESCs produce a large array of proteins?

In summary, global histone modifications in embryonic stem cells suggest that the chromatin environment is highly euchromatic and the genome is highly permissive for gene expression. This would account for the pluripotent nature of embryonic stem cells, with the genome becoming more structured, condensed, and heterochromatic during differentiation.
  • #1
TytoAlba95
132
19
'Analyses of global histone modification patterns in ESCs have previously suggested that the ESC genome is subject to generalized histone acetylation and lysine 4 H3 methylation (H3K4me). As these are both transcription-activating modifications, these changes in global genomic architecture and global histone modifications suggest that the chromatin environment in ESCs is highly euchromatic, and the genome is therefore highly permissive for gene expression. This would account for the pluripotent nature of ESCs, with the genome becoming more structured, condensed, and heterochromatic during differentiation, leading to loss of pluripotency. '

Does this mean that the ESCs make all types of hormones and enzymes that are encoded by different cells?
 
Biology news on Phys.org
  • #2
No. At very early stages, embryonic stem cells are not transcribing their genomes; instead, they rely on mRNAs provided by the mother to allow translation of many of the protein needed during the early stages of embronic development. The maternal-to-zygotic transition (in which transcription is activated from the zygotic genome and the embryo begins to rely on its own transcripts rather than transcripts provided by the mother) is associated with changes in chromatin accessibility and cells beginning upon the path of differentiation (e.g. going from totipotent cells to pleuripotent cells).

While these later stage ESCs do generally have more "open" chromatin, transcriptional regulation still occurs. An important feature of these cells are regions of "bivalent chromatin," which contains both chromatin marks associated with active transcription (e.g. H3K4me3) as well as chromatin marks associated with repression (e.g. H3K27me3). These bivalent regions are likely one way in which the early embryo can repress transcription of cell-type specific genes while still keeping them poised for activation later in development.

A good, technical review of the many changes to chromatin state that occur during embryonic development can be found here: https://science.sciencemag.org/content/361/6409/1332
 
  • Like
Likes BillTre, jim mcnamara and TytoAlba95
  • #3
Thank you so much
 

1. What are ESCs?

ESCs, or embryonic stem cells, are cells that have the potential to develop into any type of cell in the body. They are found in early-stage embryos and have the ability to self-renew and differentiate into specialized cells.

2. How do ESCs produce proteins?

ESCs produce proteins through a process called protein synthesis. This involves the transcription of DNA into messenger RNA (mRNA), which is then translated into proteins by ribosomes.

3. Do ESCs produce a large array of proteins?

Yes, ESCs have the ability to produce a large array of proteins. This is because they have the potential to differentiate into any type of cell in the body, each of which produces different proteins.

4. What types of proteins do ESCs produce?

ESCs can produce a wide range of proteins, including structural proteins, enzymes, hormones, and signaling molecules. The specific types of proteins produced depend on the type of cell that the ESCs differentiate into.

5. Can ESCs be used to produce specific proteins for medical purposes?

Yes, ESCs can be used in medical research to produce specific proteins for therapeutic purposes. By differentiating the ESCs into a specific type of cell, scientists can produce large quantities of a desired protein for use in treatments for various diseases and conditions.

Back
Top